Page 9 - Arix Bioscience News Today

Arix Bioscience PLC (ARIX) Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune 27-Apr-2023 / 07:00 GMT/BST ...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Evommune, Inc., a clinical-stage biotechnology company discovering and developing new ways to treat inflammatory diseases, today announced the...

Investegate announcements from Arix Bioscience PLC, Full Year results now to be released on 25 April 2023

Arix Bioscience plc (LON:ARIX – Get Rating) shares shot up 1.9% on Monday . The company traded as high as GBX 106 ($1.31) and last traded at GBX 105.50 ($1.31). 187,234 shares changed hands during trading, an increase of 90% from the average session volume of 98,294 shares. The stock had previously closed at GBX […]

Investegate announcements from Arix Bioscience PLC, Notice of Results and Investor Presentation

DJ Notice of Results and Investor Presentation Arix Bioscience PLC (ARIX) Notice of Results and Investor Presentation 14-Apr-2023 / 12:00 GMT/BST -----------------------------------------------------------------------------------------------------------------------

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic... | March 31, 2023

Investegate announcements from Arix Bioscience PLC, Unaudited NAV for February 2023

Investegate announcements from Brooks Macdonald Grp, Director appointment